Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 30, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 32,066	$ 42,863
Accounts receivable, net of allowance for credit losses of $2,071 and $2,006 at March 30, 2024 and December 31, 2023, respectively	104,499	104,692
Contract assets	197,056	177,686
Inventories	208,959	199,201
Production cost of contracts	7,977	7,778
Other current assets	13,388	17,349
Total Current Assets	563,945	549,569
Property and Equipment, Net of Accumulated Depreciation of $184,926 and $181,412 at March 30, 2024 and December 31, 2023, respectively	112,108	111,379
Operating Lease Right-of-Use Assets	27,489	29,513
Goodwill	244,600	244,600
Intangibles, Net	162,080	166,343
Deferred Income Taxes	641	641
Other Assets	21,190	18,874
Total Assets	1,132,053	1,120,919
Current Liabilities
Accounts payable	84,293	72,265
Contract liabilities	57,790	53,492
Accrued and other liabilities	29,311	42,260
Operating lease liabilities	7,745	7,873
Current portion of long-term debt	9,375	7,813
Total Current Liabilities	188,514	183,703
Long-Term Debt, Less Current Portion	253,929	256,961
Non-Current Operating Lease Liabilities	21,016	22,947
Deferred Income Taxes	4,439	4,766
Other Long-Term Liabilities	18,608	16,448
Total Liabilities	486,506	484,825
Commitments and Contingencies (Notes 10, 12)
Shareholders’ Equity
Common Stock - $0.01 par value; 35,000,000 shares authorized; 14,706,626 and 14,600,766 shares issued and outstanding at March 30, 2024 and December 31, 2023, respectively	147	146
Additional Paid-In Capital	206,557	206,197
Retained Earnings	428,829	421,980
Accumulated Other Comprehensive Income	10,014	7,771
Total Shareholders’ Equity	645,547	636,094
Total Liabilities and Shareholders’ Equity	$ 1,132,053	$ 1,120,919